{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:46:23Z","timestamp":1791413183778,"version":"4.3.3"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5P01AI131276"],"award-info":[{"award-number":["5P01AI131276"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5P01AI131276"],"award-info":[{"award-number":["5P01AI131276"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5P01AI131276"],"award-info":[{"award-number":["5P01AI131276"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5P01AI131276"],"award-info":[{"award-number":["5P01AI131276"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5P01AI131276"],"award-info":[{"award-number":["5P01AI131276"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5P01AI131276"],"award-info":[{"award-number":["5P01AI131276"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5UM1AI164566"],"award-info":[{"award-number":["5UM1AI164566"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5UM1AI164566"],"award-info":[{"award-number":["5UM1AI164566"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5UM1AI164566"],"award-info":[{"award-number":["5UM1AI164566"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5P01AI117915"],"award-info":[{"award-number":["5P01AI117915"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["P51OD011132"],"award-info":[{"award-number":["P51OD011132"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["P40OD028116"],"award-info":[{"award-number":["P40OD028116"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["P40OD028116"],"award-info":[{"award-number":["P40OD028116"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>\n                    To eliminate vertical HIV transmission and achieve therapy-free viral suppression among children living with HIV, novel strategies beyond antiretroviral therapy (ART) are necessary. Our group previously identified a triple broadly neutralizing antibody (bNAb) combination comprising of 3BNC117, PGDM1400 and PGT151 that mediates robust\n                    <jats:italic>in vitro<\/jats:italic>\n                    neutralization and non-neutralizing effector functions against a cross-clade panel of simian human immunodeficiency viruses (SHIVs). In this study, we evaluated the safety, pharmacokinetics, and antiviral potency of this bNAb combination in infant rhesus macaques (RMs). We demonstrate that subcutaneous infusion of the triple bNAb regimen was well tolerated in pediatric monkeys and resulted in durable systemic and mucosal distribution. Plasma obtained from passively-immunized RMs demonstrated potent HIV-neutralizing and Fc-mediated antiviral effector functions. Finally, using the predicted serum neutralization 80% inhibitory dilution titer (PT\n                    <jats:sub>80<\/jats:sub>\n                    ) biomarker threshold of &gt;200, which was recently identified as a surrogate endpoint for evaluation of the preventative efficacy of bNAbs against mucosal viral acquisition in human clinical trials, we demonstrated that our regimen has PT\n                    <jats:sub>80<\/jats:sub>\n                    &gt;200 against a large panel of plasma and breast milk-derived HIV strains and cross-clade SHIV variants. This data will guide the development of combination bNAbs for eliminating vertical HIV transmission and for achieving ART-free viral suppression among children living with HIV.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0312411","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T13:33:31Z","timestamp":1731332011000},"page":"e0312411","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["A novel HIV triple broadly neutralizing antibody (bNAb) combination-based passive immunization of infant rhesus macaques achieves durable protective plasma neutralization levels and mediates anti-viral effector functions"],"prefix":"10.1371","volume":"19","author":[{"given":"Sedem","family":"Dankwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Kosman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena E.","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Pahountis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Binuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2258-5276","authenticated-orcid":true,"given":"Bryan T.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia T.","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiamaka A.","family":"Enemuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane G.","family":"Carnathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Stanfield-Oakley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella J.","family":"Berendam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Weinbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Engelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo M.","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliburn","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama R.","family":"Amara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Chahroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sallie R.","family":"Permar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve G.","family":"Fouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4574-5431","authenticated-orcid":true,"given":"Ria","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"key":"pone.0312411.ref001","article-title":"Global HIV & AIDS statistics\u2014Fact sheet","author":"UNAIDS","year":"2023"},{"issue":"7","key":"pone.0312411.ref002","doi-asserted-by":"crossref","first-page":"e0132262","DOI":"10.1371\/journal.pone.0132262","article-title":"Time of HIV Diagnosis and Engagement in Prenatal Care Impact Virologic Outcomes of Pregnant Women with HIV.","volume":"10","author":"FM Momplaisir","year":"2015","journal-title":"PLOS ONE."},{"key":"pone.0312411.ref003","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2147\/PPA.S354242","article-title":"Adherence to HIV Antiretroviral Therapy Among Pregnant and Breastfeeding Women, Non-Pregnant Women, and Men in Burkina Faso: Nationwide Analysis 2019\u20132020.","volume":"16","author":"WN Zoungrana-Yameogo","year":"2022","journal-title":"Patient Prefer Adherence."},{"key":"pone.0312411.ref004","doi-asserted-by":"crossref","first-page":"c6580","DOI":"10.1136\/bmj.c6580","article-title":"Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study","volume":"341","author":"JH Humphrey","year":"2010","journal-title":"Bmj"},{"issue":"6","key":"pone.0312411.ref005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/ni.3152","article-title":"HIV reservoirs as obstacles and opportunities for an HIV cure","volume":"16","author":"T-W Chun","year":"2015","journal-title":"Nature Immunology"},{"issue":"4","key":"pone.0312411.ref006","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/OLQ.0000000000001366","article-title":"Estimated Lifetime HIV-Related Medical Costs in the United States.","volume":"48","author":"A Bingham","year":"2021","journal-title":"Sex Transm Dis."},{"issue":"2","key":"pone.0312411.ref007","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40121-018-0201-6","article-title":"A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population.","volume":"7","author":"A Chawla","year":"2018","journal-title":"Infect Dis Ther."},{"issue":"1","key":"pone.0312411.ref008","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4102\/sajhivmed.v20i1.1002","article-title":"Challenges to HIV treatment adherence amongst adolescents in a low socio-economic setting in Cape Town.","volume":"20","author":"BE van Wyk","year":"2019","journal-title":"South Afr J HIV Med"},{"key":"pone.0312411.ref009","first-page":"712122","article-title":"Broadly Neutralizing Antibodies for HIV-1 Prevention","volume":"12","author":"SR Walsh","year":"2021"},{"issue":"7427","key":"pone.0312411.ref010","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature11604","article-title":"HIV therapy by a combination of broadly neutralizing antibodies in humanized mice","volume":"492","author":"F Klein","year":"2012","journal-title":"Nature"},{"issue":"3","key":"pone.0312411.ref011","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.chom.2019.08.014","article-title":"A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge","volume":"26","author":"A Pegu","year":"2019","journal-title":"Cell Host Microbe"},{"issue":"11","key":"pone.0312411.ref012","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1056\/NEJMoa2031738","article-title":"Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1","volume":"384","author":"L Corey","year":"2021","journal-title":"Acquisition. New England Journal of Medicine"},{"issue":"21","key":"pone.0312411.ref013","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1056\/NEJMoa1608243","article-title":"Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption","volume":"375","author":"KJ Bar","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"7613","key":"pone.0312411.ref014","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature18929","article-title":"HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption","volume":"535","author":"JF Scheid","year":"2016","journal-title":"Nature"},{"issue":"7557","key":"pone.0312411.ref015","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nature14411","article-title":"Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117","volume":"522","author":"M Caskey","year":"2015","journal-title":"Nature"},{"issue":"6","key":"pone.0312411.ref016","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41591-022-01815-1","article-title":"Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial","volume":"28","author":"B Julg","year":"2022","journal-title":"Nature Medicine"},{"issue":"2","key":"pone.0312411.ref017","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nm.4268","article-title":"Antibody 10\u20131074 suppresses viremia in HIV-1-infected individuals","volume":"23","author":"M Caskey","year":"2017","journal-title":"Nature Medicine"},{"issue":"7913","key":"pone.0312411.ref018","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41586-022-04797-9","article-title":"Combination anti-HIV antibodies provide sustained virological suppression","volume":"606","author":"MC Sneller","year":"2022","journal-title":"Nature"},{"issue":"703","key":"pone.0312411.ref019","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adh0004","article-title":"Broadly neutralizing antibody treatment maintained HIV suppression in children with favorable reservoir characteristics in Botswana.","volume":"15","author":"RL Shapiro","year":"2023","journal-title":"Sci Transl Med."},{"issue":"1","key":"pone.0312411.ref020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/pharmaceutics3010053","article-title":"Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults.","volume":"3","author":"E Fernandez","year":"2011","journal-title":"Pharmaceutics"},{"issue":"6049","key":"pone.0312411.ref021","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"JF Scheid","year":"2011","journal-title":"Science"},{"issue":"49","key":"pone.0312411.ref022","doi-asserted-by":"crossref","first-page":"17624","DOI":"10.1073\/pnas.1415789111","article-title":"Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex","volume":"111","author":"D Sok","year":"2014","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"5","key":"pone.0312411.ref023","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.immuni.2014.04.009","article-title":"Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers","volume":"40","author":"E Falkowska","year":"2014","journal-title":"Immunity"},{"issue":"3","key":"pone.0312411.ref024","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01667-20","article-title":"Systematic Assessment of Antiviral Potency, Breadth, and Synergy of Triple Broadly Neutralizing Antibody Combinations against Simian-Human Immunodeficiency Viruses","volume":"95","author":"SJ Berendam","year":"2021","journal-title":"J Virol"},{"issue":"11","key":"pone.0312411.ref025","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1128\/JVI.00210-15","article-title":"Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian\/Human Immunodeficiency Virus Infection","volume":"89","author":"KO Saunders","year":"2015","journal-title":"J Virol"},{"issue":"5","key":"pone.0312411.ref026","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01971-19","article-title":"Analytical Treatment Interruption after Short-Term Antiretroviral Therapy in a Postnatally Simian-Human Immunodeficiency Virus-Infected Infant Rhesus Macaque Model.","volume":"10","author":"R Goswami","year":"2019","journal-title":"mBio"},{"issue":"18","key":"pone.0312411.ref027","article-title":"Simian-Human Immunodeficiency Virus SHIV.CH505 Infection of Rhesus Macaques Results in Persistent Viral Replication and Induces Intestinal Immunopathology","volume":"93","author":"KJ Bar","year":"2019","journal-title":"J Virol"},{"issue":"9","key":"pone.0312411.ref028","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1038\/s41591-022-01953-6","article-title":"Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition","volume":"28","author":"PB Gilbert","year":"2022","journal-title":"Nature Medicine"},{"issue":"5","key":"pone.0312411.ref029","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1128\/JVI.02853-13","article-title":"Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies","volume":"88","author":"A deCamp","year":"2014","journal-title":"J Virol"},{"key":"pone.0312411.ref030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-4690-10-3","article-title":"Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants.","volume":"10","author":"GG Fouda","year":"2013","journal-title":"Retrovirology."},{"issue":"11","key":"pone.0312411.ref031","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/infdis\/jiab229","article-title":"Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants.","volume":"224","author":"EJ McFarland","year":"2021","journal-title":"J Infect Dis"},{"issue":"1","key":"pone.0312411.ref032","doi-asserted-by":"crossref","first-page":"e26052","DOI":"10.1002\/jia2.26052","article-title":"Cost-effectiveness of broadly neutralizing antibody prophylaxis for HIV-exposed infants in sub-Saharan African settings","volume":"26","author":"CM Dugdale","year":"2023","journal-title":"Journal of the International AIDS Society"},{"issue":"1","key":"pone.0312411.ref033","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41467-019-13972-y","article-title":"Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunity","volume":"11","author":"MB Shapiro","year":"2020","journal-title":"Nature Communications"},{"issue":"20","key":"pone.0312411.ref034","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01187-17","article-title":"Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity against Simian-Human Immunodeficiency Virus in Rhesus Monkeys","volume":"91","author":"B Julg","year":"2017","journal-title":"J Virol"},{"key":"pone.0312411.ref035","article-title":"Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants NCT02256631","author":"ClinicalTrials.gov"},{"issue":"4","key":"pone.0312411.ref036","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/infdis\/jiz532","article-title":"Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants.","volume":"222","author":"CK Cunningham","year":"2019","journal-title":"The Journal of Infectious Diseases"},{"issue":"3","key":"pone.0312411.ref037","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bcp.12267","article-title":"Paediatric pharmacokinetics: key considerations","volume":"79","author":"HK Batchelor","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"pone.0312411.ref038","doi-asserted-by":"crossref","first-page":"e0219142","DOI":"10.1371\/journal.pone.0219142","article-title":"Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10\u20131074 in healthy adults: A randomized, phase 1 study.","volume":"14","author":"YZ Cohen","year":"2019","journal-title":"PLOS ONE"},{"issue":"10","key":"pone.0312411.ref039","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1084\/jem.20132494","article-title":"Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques","volume":"211","author":"M Shingai","year":"2014","journal-title":"J Exp Med"},{"issue":"4","key":"pone.0312411.ref040","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nm.4063","article-title":"Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques","volume":"22","author":"AJ Hessell","year":"2016","journal-title":"Nat Med"},{"issue":"7524","key":"pone.0312411.ref041","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nature13612","article-title":"Enhanced neonatal Fc receptor function improves protection against primate SHIV infection","volume":"514","author":"SY Ko","year":"2014","journal-title":"Nature"},{"issue":"2","key":"pone.0312411.ref042","doi-asserted-by":"crossref","first-page":"e0164321","DOI":"10.1128\/JVI.01643-21","article-title":"Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies","volume":"96","author":"D Mielke","year":"2022","journal-title":"J Virol"},{"issue":"1","key":"pone.0312411.ref043","doi-asserted-by":"crossref","first-page":"e1002493","DOI":"10.1371\/journal.pmed.1002493","article-title":"Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults.","volume":"15","author":"MR Gaudinski","year":"2018","journal-title":"PLoS Med."},{"issue":"2","key":"pone.0312411.ref044","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01669-20","article-title":"Simian-Human Immunodeficiency Virus SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques Is Characterized by Elevated SHIV RNA in the Gut and a High Abundance of Intact SHIV DNA in Naive CD4(+) T Cells.","volume":"95","author":"V Obregon-Perko","year":"2020","journal-title":"J Virol"},{"key":"pone.0312411.ref045","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-1-59745-170-3_26","article-title":"Measuring HIV neutralization in a luciferase reporter gene assay","volume":"485","author":"DC Montefiori","year":"2009","journal-title":"Methods Mol Biol"},{"issue":"14","key":"pone.0312411.ref046","doi-asserted-by":"crossref","first-page":"7715","DOI":"10.1128\/JVI.00156-14","article-title":"HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities","volume":"88","author":"J Pollara","year":"2014","journal-title":"J Virol"},{"issue":"1","key":"pone.0312411.ref047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2010.08.028","article-title":"Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC","volume":"408","author":"TG Edmonds","year":"2010","journal-title":"Virology"},{"issue":"8","key":"pone.0312411.ref048","doi-asserted-by":"crossref","first-page":"e1005817","DOI":"10.1371\/journal.ppat.1005817","article-title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses.","volume":"12","author":"MZ Tay","year":"2016","journal-title":"PLoS Pathog."},{"issue":"4","key":"pone.0312411.ref049","doi-asserted-by":"crossref","first-page":"e1010003","DOI":"10.1371\/journal.pcbi.1010003","article-title":"Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention","volume":"18","author":"BT Mayer","year":"2022","journal-title":"PLOS Computational Biology"},{"issue":"W1","key":"pone.0312411.ref050","doi-asserted-by":"crossref","first-page":"W213","DOI":"10.1093\/nar\/gkv404","article-title":"CATNAP: a tool to compile, analyze and tally neutralizing antibody panels","volume":"43","author":"H Yoon","year":"2015","journal-title":"Nucleic Acids Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0312411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T13:33:45Z","timestamp":1731332025000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0312411"}},"subtitle":[],"editor":[{"given":"Roland","family":"Zahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0312411","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.10.09.561559","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]}}}